The latest on the march toward a successful coronavirus vaccine
Advertisement
Lydia Ramsey Pflanzer
Nov 20, 2020, 22:21 IST
Hollis Johnson/Business Insider
Hello,
Advertisement
It feels so dissonant — the good news about vaccines working at the same time as case counts are rising even higher, New York's shutting down its schools, and states and cities are making the tough decisions to lock back down in the hopes of mitigating even further spread of the virus.
But that's indeed where we find ourselves in November 2020. How's everyone holding up? Has anyone restarted a hobby? My sourdough starter's back from hibernation as part of the move, ready for a winter's worth of baking.
What's for sure is that Amazon building up its pharmacy business has implications for all different parts of the healthcare system, from health plans, to retail pharmacies, to startups also looking to shake up the pharmacy world.
When she wasn't diving deep into Amazon's impact on the healthcare industry, Shelby was mapping out how much pharmacies, doctor's offices, and hospitals stand to profit from administering coronavirus vaccines.
I'll be off next Friday, so your next weekly download on healthcare news will be in your inboxes in December (!). In the meantime, I'm wishing you all safe and restful Thanksgivings. Me, I'll be attempting my first pies at altitude, wish me luck!
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.
Nearly 3,500 federal employees will receive compensation from the US government for contracting COVID-19 at work
People who develop COVID-19 antibodies are unlikely to get the virus again for at least 6 months, a new Oxford University study of more than 12,000 people suggests
Pfizer just asked the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people